These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 35137787

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. The effect of combined therapy for treatment of monotherapy-resistant PDA in preterm infants.
    Yurttutan S, Bozkaya A, Hüdayioglu F, Oncel MY.
    J Matern Fetal Neonatal Med; 2019 Nov; 32(21):3662-3665. PubMed ID: 29921134
    [Abstract] [Full Text] [Related]

  • 45. Neurodevelopmental Outcomes of Preterm Infants Treated with Oral Paracetamol Versus Ibuprofen for Patent Ductus Arteriosus.
    Oncel MY, Eras Z, Uras N, Canpolat FE, Erdeve O, Oguz SS.
    Am J Perinatol; 2017 Oct; 34(12):1185-1189. PubMed ID: 28395364
    [Abstract] [Full Text] [Related]

  • 46. Low dose paracetamol for management of patent ductus arteriosus in very preterm infants: a randomised non-inferiority trial.
    Balasubramanian H, Jain V, Bhalgat P, Parikh S, Kabra N, Mohan D, Sheth K.
    Arch Dis Child Fetal Neonatal Ed; 2023 Mar; 108(2):130-135. PubMed ID: 35940873
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Comparative safety and efficacy of paracetamol versus non-steroidal anti-inflammatory agents in neonates with patent ductus arteriosus: A systematic review and meta-analysis of randomized controlled trials.
    Katsaras DN, Katsaras GN, Chatziravdeli VI, Papavasileiou GN, Touloupaki M, Mitsiakos G, Doxani C, Stefanidis I, Dardiotis E.
    Br J Clin Pharmacol; 2022 Jul; 88(7):3078-3100. PubMed ID: 35203104
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants.
    Vidavalur R.
    Paediatr Drugs; 2022 Mar; 24(2):93-102. PubMed ID: 35229248
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A, Walia R, Shah SS.
    Cochrane Database Syst Rev; 2010 Apr 14; (4):CD003481. PubMed ID: 20393936
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study.
    Abushanab D, Rouf PA, Al Hail M, Kamal R, Viswanathan B, Parappil H, Elkassem W, Al-Shaibi S, Al-Badriyeh D.
    Clin Ther; 2021 Feb 14; 43(2):336-348.e7. PubMed ID: 33431169
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Different approaches for patent ductus arteriosus in premature infants using acetaminophen.
    Surak A, Jain A, Hyderi A.
    World J Pediatr; 2022 Apr 14; 18(4):243-250. PubMed ID: 35253098
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.